FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On April 27, 2004
Table of Contents
Docket # Title
1976N-0151 Isocarboxazid
1977N-0203 Tranylcypromine Sulfate
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999D-0529 Draft Guidance for Ind - Changes to an Approved NDA or ANDA
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
2003D-0570 Draft on the Clinical Evaluation of Weight-Control Drugs
2003P-0555 Maintain the Electroconvulsive Therapy Device in Class III for All Indications
2004D-0042 Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
2004N-0115 Prescription Drug Importation Study
2004N-0176 Preparation for the International Conference on Harmonization Meetings in Washington, DC: Public Meeting
2004P-0105 Nutrient Content Claim: Total Carbohydrate Content of Foods
2004P-0107 Nutrient Content Claim: Carbohydrate Content of Foods
2004P-0110 Nutrient Content Claim: Carbohydrate Content of Foods
2004P-0167 ANADA for a generic equivalent of the innovator products, Garacin (gentamicin sulfate) Pig Pump Oral Solution
2004P-0183 Nutrient Content Claim: Expand Lean Definition
2004P-0195 ANDA Suitability for Divalproex Sodium Extended-Release Tablets, 750 mg
2004P-0196 ANDA for ribavirin, USP tablets in stengths of 400 mg and 600mg
2004P-0197 ANADA for Pig Pump Oral Solution, NADA 130-464
1976N-0151 Isocarboxazid
NPH 2 FDA Vol #: 1
1977N-0203 Tranylcypromine Sulfate
NPH 2 FDA Vol #: 1
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
RPT 177
Attachments
Hi Tech Pharma Inc Vol #: 132
RPT 178 Exceeding Corp. Vol #: 132
RPT 179
Attachments
BSP Pharm A/S Vol #: 132
RPT 180 Cyber Store LLC Vol #: 133
RPT 181
Attachments
Advanced Orthomolecular Research Vol #: 133
RPT 182 Amino GmbH Vol #: 134
RPT 183 Hormo Nutraceutical Oy Ltd Vol #: 133
RPT 184 Mark Weiner Vol #: 133
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 13795 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13796 Herb Pharm Vol #: 117
LET 13797 Perrigo Company of South Carolina Vol #: 117
LET 13798 Perrigo Company of South Carolina Vol #: 117
LET 13799 Perrigo Company of South Carolina Vol #: 117
LET 13800 Perrigo Company of South Carolina Vol #: 117
LET 13801 Perrigo Company of South Carolina Vol #: 117
LET 13802 EuroPharma, Inc. Vol #: 117
LET 13803 Perrigo Company of South Carolina Vol #: 117
LET 13804 Optimum Nutrition Vol #: 117
LET 13805 Melaleuca, Inc. Vol #: 117
LET 13806 Source Naturals Vol #: 117
LET 13807 Flora, Inc. Vol #: 117
LET 13808 Weleda, Inc. Vol #: 117
LET 13809 FoodScience of Vermont Vol #: 117
LET 13810 Botanical Laboratories Vol #: 117
LET 13811 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13812 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13813 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13814 NBTY, Inc. Vol #: 117
LET 13815 NBTY, Inc. Vol #: 117
LET 13816 NBTY, Inc. Vol #: 117
LET 13817 NBTY, Inc. Vol #: 117
LET 13818 NBTY, Inc. Vol #: 117
LET 13819 NBTY, Inc. Vol #: 117
LET 13820 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13821 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13822 Enzymatic Therapy Natural Medicines Vol #: 117
LET 13823 Synergy Worldwide Vol #: 117
LET 13824 PhytoPharmica Natural Medicines Vol #: 117
LET 13825 Nutrivention Nutritional Programs Vol #: 117
LET 13826 Pharmanex, LLC Vol #: 117
LET 13827 NBTY, Inc. Vol #: 117
LET 13828 NBTY, Inc. Vol #: 117
LET 13829 NBTY, Inc. Vol #: 117
LET 13830 NBTY, Inc. Vol #: 117
LET 13831 NBTY, Inc. Vol #: 117
LET 13832 NBTY, Inc. Vol #: 117
LET 13833 NBTY, Inc. Vol #: 117
LET 13834 NBTY, Inc. Vol #: 117
LET 13835 Advocare International, L.P. Vol #: 117
1999D-0529 Draft Guidance for Ind - Changes to an Approved NDA or ANDA
NCR 1 FDA Vol #: 5
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EMC 667 Form Letter Vol #: 402
EMC 668 Sandy McClure Vol #: 271
EMC 669 Joseph Staples Vol #: 271
EMC 670 Diane Lindahl Vol #: 271
EMC 671 Nathan Bixby Vol #: 271
EMC 672 Yolanda Garcia Vol #: 271
EMC 673 Laurel Kearns Vol #: 271
EMC 674 David Beumee Vol #: 271
EMC 675 Kathy Carson Vol #: 271
EMC 676 Andy Belk Vol #: 271
EMC 677 Clare Loftin Vol #: 271
EMC 678 Patricia Donovan Vol #: 271
EMC 679 Jef Cameron-Martin Vol #: 271
EMC 680 Joan Walker Vol #: 271
EMC 681 Ron Carswell Vol #: 271
EMC 682 Marie Ryan Vol #: 271
EMC 683 Darius Sivin Vol #: 271
EMC 684 Rev. Roger Wolsey Vol #: 271
EMC 685 Arthur Fitzgerald Vol #: 271
EMC 686 Michael Stites Vol #: 271
EMC 687 Kay James Vol #: 271
EMC 688 Lois Joseph Vol #: 271
EMC 689 Bill & Marilyn Voohies Vol #: 271
EMC 690 Deborah Nation Vol #: 271
EMC 691 Lynda Bagot-Parker Vol #: 271
EMC 692 Ann Hansen Vol #: 271
EMC 693 Bob Fischella Vol #: 271
EMC 694 Harry Rothwell Vol #: 271
EMC 695 Barbara Jones Vol #: 271
EMC 696 Diane Wonio Vol #: 271
EMC 697 Eleen Onda Vol #: 271
EMC 698 Richard Haberstroh Vol #: 271
EMC 699 Patricia R. Hopkins Vol #: 271
EMC 700 Ann Berquist Vol #: 271
EMC 701 Michele A. Carson Vol #: 271
EMC 702 Frances Perlman Vol #: 271
EMC 703 Dolly Kaplan Vol #: 271
EMC 704 Kristi Herlein Vol #: 271
EMC 705 Barry Sapp Vol #: 271
EMC 706 Nina Olff Vol #: 271
EMC 707 Ocie Hudson Vol #: 271
EMC 708 Karen McAnnally Vol #: 271
EMC 709 Jessica Goodwin Vol #: 271
EMC 710 Jennifer Heavilin Vol #: 271
EMC 711 Diane Nunn Vol #: 271
EMC 712 Rev. B. J. Doucet Vol #: 271
EMC 713 John Thomson Vol #: 271
EMC 714 Katherine Kilroy Vol #: 271
EMC 715 Benjamin Israel Vol #: 271
EMC 716 Rachel West Vol #: 271
EMC 717 William Frazier Vol #: 271
EMC 718 Carole Zdesar Vol #: 271
EMC 719 Scott Bruins Vol #: 271
EMC 720 Barbara Ann Dembek, M.A. Vol #: 271
EMC 721 Dale Ann Cox Vol #: 271
EMC 722 Kirk Jacobsen Vol #: 271
EMC 723 J. K. Fort-Strietzel Vol #: 271
EMC 724 Pat Blair Vol #: 271
EMC 725 Robert Loucks Vol #: 271
EMC 726 Dorothea Herron Vol #: 271
EMC 727 Peter Rickwood Vol #: 271
EMC 728 Patrick Sullivan Vol #: 271
EMC 729 Janet Chavez Vol #: 271
EMC 730 Christina Shepherd Vol #: 271
EMC 731 Corinne Canavero Vol #: 271
EMC 732 Melissa Huling Vol #: 271
EMC 733 Sherry Price Vol #: 271
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 6101 S. Abbott Vol #: 234
EMC 6102 Mrs. F. M. Cone Vol #: 234
EMC 6103 N. Jentz Vol #: 234
EMC 6104 E. Hollingshead Vol #: 234
EMC 6105 K. Berra Vol #: 234
EMC 6106 M. Gillespie Vol #: 234
EMC 6107 J. Cloud Vol #: 234
EMC 6108 J. Burgderfer Vol #: 234
EMC 6109 E. R. Greenspan Vol #: 234
EMC 6110 Jenny C. Vol #: 234
EMC 6111 L. H. Madsen Vol #: 234
EMC 6112 J. Titus Vol #: 234
EMC 6113 R. L. Nicolay Vol #: 234
EMC 6114 R. Rallo Vol #: 234
EMC 6115 J. Brinn Vol #: 234
EMC 6116 J. Thoms Vol #: 234
EMC 6117 B. Linsey Vol #: 234
EMC 6118 G. Toomey Vol #: 234
EMC 6119 J. Busbey Vol #: 234
EMC 6120 P. Griffith Vol #: 234
EMC 6121 B. Dayton Vol #: 234
EMC 6122 B. Noehl Vol #: 234
EMC 6123 J. Kobran Vol #: 234
EMC 6124 A. Magee Vol #: 234
EMC 6125 D. Cabrera Vol #: 234
EMC 6126 T. Keenan Vol #: 234
EMC 6127 V. Goodrich Vol #: 234
EMC 6128 R. Taylor Vol #: 234
EMC 6129 C. Stoltz Vol #: 234
EMC 6130 M. Fong Vol #: 234
EMC 6131 D. Dobric Vol #: 234
EMC 6132 J. Robbins Vol #: 234
EMC 6133 L. Woodry Vol #: 234
EMC 6134 B. Allen Vol #: 234
EMC 6135 P. Gassner Vol #: 234
EMC 6136 S. Fisher Vol #: 234
EMC 6137 A. H. Lerner, M.D. Vol #: 234
EMC 6138 L. Nastro Vol #: 245
EMC 6139 J. T. Carlson Vol #: 234
EMC 6140 B. Noble Vol #: 234
EMC 6141 B. J. McLendon Vol #: 234
EMC 6142 J. Cahill-Dutiel Vol #: 234
EMC 6143 A. Steeneck Vol #: 234
EMC 6144 C. Mayes Vol #: 234
EMC 6145 W. Velez Vol #: 234
EMC 6146 J. Barrett Vol #: 234
EMC 6147 A. Watts Vol #: 234
EMC 6148 C. Ferguson Vol #: 234
EMC 6149 E. Charlton Vol #: 234
EMC 6150 F. Slater Vol #: 234
EMC 6151 I. L. Else Vol #: 234
EMC 6152 W. Bowman Vol #: 234
EMC 6153 T. Marafiote Vol #: 234
EMC 6154 B. Stewart Vol #: 234
EMC 6155 L.Parker Vol #: 234
EMC 6156 J. Burean Vol #: 234
EMC 6157 J. Brann Vol #: 234
EMC 6158 M. Leavitt Vol #: 234
EMC 6159 S. Berzac Vol #: 234
EMC 6160 A. Corbett Vol #: 234
EMC 6161 J. Sina Vol #: 234
2003D-0478 Guidance on Marketed Unapproved Drugs Compliance Policy Guide
C 69 PFab, LP, d/b/a PharmaFab Vol #: 5
2003D-0570 Draft on the Clinical Evaluation of Weight-Control Drugs
C 4 GlaxoSmithKline (GSK) Vol #: 1
C 5 Nastech Pharmaceutical Company, Inc. (NASTECH) Vol #: 1
C 6 Hoffmann-La Roche Inc. Vol #: 1
C 7 Pharmaceutical Research and Manufacturers of America (PhRMA) Vol #: 1
C 8 Johnson & Johnson Pharmaceutical Research & Development, LLC Vol #: 1
C 9 Amylin Pharmaceuticals, Inc. (AMYLIN) Vol #: 1
C 10 Pfizer, Inc. Vol #: 1
2003P-0555 Maintain the Electroconvulsive Therapy Device in Class III for All Indications
C 11 R and A Harper Vol #: 2
2004D-0042 Guidances for Industry on Improving Direct-to-Consumer Advertising for Medical Products
C 3 Center for Medical Consumers Vol #: 1
C 4 Center for Medical Consumers Vol #: 1
2004N-0115 Prescription Drug Importation Study
APE 19 Consumer Alert Vol #: 3
2004N-0176 Preparation for the International Conference on Harmonization Meetings in Washington, DC: Public Meeting
NM 1 FDA Vol #: 1
2004P-0105 Nutrient Content Claim: Total Carbohydrate Content of Foods
C 1 Kevin Asip Vol #: 1
LET 1 HFS-200 to Kraft Foods North America, Inc. Vol #: 1
2004P-0107 Nutrient Content Claim: Carbohydrate Content of Foods
C 1 K. Asip Vol #: 1
LET 1 HFS-200 to Office of Product Quality and Development Vol #: 1
2004P-0110 Nutrient Content Claim: Carbohydrate Content of Foods
C 1 K. Asip Vol #: 1
LET 1 HFS-200 to Grocery Manufacturers of America Vol #: 1
LET 2 HFS-200 to Grocery Manufacturers of America Vol #: 1
2004P-0167 ANADA for a generic equivalent of the innovator products, Garacin (gentamicin sulfate) Pig Pump Oral Solution
WDL 1 First Priority, Inc. Vol #: 1
2004P-0183 Nutrient Content Claim: Expand Lean Definition
ACK 1 HFS-832 to Nestle Prepared Foods Company Vol #: 1
C 1 C. Williams,MD,MPH Vol #: 4
CP 1
Petition, Attachments
Nestle Prepared Foods Company (Nestle) Vol #: 1
2004P-0195 ANDA Suitability for Divalproex Sodium Extended-Release Tablets, 750 mg
ACK 1 HFA-305 to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1
2004P-0196 ANDA for ribavirin, USP tablets in stengths of 400 mg and 600mg
ACK 1 HFA-305 to Fommer Lawrence & Haug LLP Vol #: 1
CP 1
Tabs
Fommer Lawrence & Haug LLP Vol #: 1
2004P-0197 ANADA for Pig Pump Oral Solution, NADA 130-464
ACK 1 HFA-305 to First Priority, Inc. Vol #: 1
CP 1 First Priority, Inc. Vol #: 1

Page created on April 28, 2004 kk
Page updated on May 3, 2004 rsc

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management